These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7806544)

  • 21. Molecular basis for the thiol sensitivity of insulin-degrading enzyme.
    Neant-Fery M; Garcia-Ordoñez RD; Logan TP; Selkoe DJ; Li L; Reinstatler L; Leissring MA
    Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9582-7. PubMed ID: 18621727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the allosteric regulatory site of insulysin.
    Noinaj N; Bhasin SK; Song ES; Scoggin KE; Juliano MA; Juliano L; Hersh LB; Rodgers DW
    PLoS One; 2011; 6(6):e20864. PubMed ID: 21731629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
    Kuo WL; Gehm BD; Rosner MR
    Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anion activation site of insulin-degrading enzyme.
    Noinaj N; Song ES; Bhasin S; Alper BJ; Schmidt WK; Hersh LB; Rodgers DW
    J Biol Chem; 2012 Jan; 287(1):48-57. PubMed ID: 22049080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of glutamic acid 646 as a zinc-coordinating residue in endopeptidase-24.11.
    Le Moual H; Devault A; Roques BP; Crine P; Boileau G
    J Biol Chem; 1991 Aug; 266(24):15670-4. PubMed ID: 1678740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
    Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
    Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme.
    Glebov K; Schütze S; Walter J
    J Biol Chem; 2011 Jul; 286(26):22711-5. PubMed ID: 21576244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE.
    Schmalen A; Karius-Fischer J; Rauch P; Setz C; Korn K; Henklein P; Fossen T; Schubert U
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
    Authier F; Rachubinski RA; Posner BI; Bergeron JJ
    J Biol Chem; 1994 Jan; 269(4):3010-6. PubMed ID: 8300632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
    Haque R; Nazir A
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX.
    McCafferty DG; Lessard IA; Walsh CT
    Biochemistry; 1997 Aug; 36(34):10498-505. PubMed ID: 9265630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line.
    Kuo WL; Gehm BD; Rosner MR; Li W; Keller G
    J Biol Chem; 1994 Sep; 269(36):22599-606. PubMed ID: 8077210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
    Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
    J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Families of zinc metalloproteases.
    Hooper NM
    FEBS Lett; 1994 Oct; 354(1):1-6. PubMed ID: 7957888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.
    Kurochkin IV
    FEBS Lett; 1998 May; 427(2):153-6. PubMed ID: 9607302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
    Leissring MA; Malito E; Hedouin S; Reinstatler L; Sahara T; Abdul-Hay SO; Choudhry S; Maharvi GM; Fauq AH; Huzarska M; May PS; Choi S; Logan TP; Turk BE; Cantley LC; Manolopoulou M; Tang WJ; Stein RL; Cuny GD; Selkoe DJ
    PLoS One; 2010 May; 5(5):e10504. PubMed ID: 20498699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.